ELAVL1 and metabolic dysfunction-associated steatotic liver disease: In this section, we provide a brief overview of HuR’s emerging roles in extrahepatic metabolic diseases commonly associated with MASLD, highlighting its potential contribution to the broader metabolic syndrome context.